BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 23581279)

  • 1. SUMOylation is a regulator of the translocation of Jak2 between nucleus and cytosol.
    Sedek M; Strous GJ
    Biochem J; 2013 Jul; 453(2):231-9. PubMed ID: 23581279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
    Morales O; Lindgren U; Haldosén LA
    J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear JAK2: form and function in cancer.
    Qian CJ; Yao J; Si JM
    Anat Rec (Hoboken); 2011 Sep; 294(9):1446-59. PubMed ID: 21809458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipase Cgamma1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B.
    Choi JH; Kim HS; Kim SH; Yang YR; Bae YS; Chang JS; Kwon HM; Ryu SH; Suh PG
    Nat Cell Biol; 2006 Dec; 8(12):1389-97. PubMed ID: 17128263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual insertion in Jak2 is crucial for kinase activity and differentially affects cytokine responses.
    Haan C; Kroy DC; Wüller S; Sommer U; Nöcker T; Rolvering C; Behrmann I; Heinrich PC; Haan S
    J Immunol; 2009 Mar; 182(5):2969-77. PubMed ID: 19234192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jak2 is a negative regulator of ubiquitin-dependent endocytosis of the growth hormone receptor.
    Putters J; da Silva Almeida AC; van Kerkhof P; van Rossum AG; Gracanin A; Strous GJ
    PLoS One; 2011 Feb; 6(2):e14676. PubMed ID: 21347402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
    Miquet JG; Sotelo AI; Bartke A; Turyn D
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.
    Hoermann G; Cerny-Reiterer S; Herrmann H; Blatt K; Bilban M; Gisslinger H; Gisslinger B; Müllauer L; Kralovics R; Mannhalter C; Valent P; Mayerhofer M
    FASEB J; 2012 Feb; 26(2):894-906. PubMed ID: 22051730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone.
    Yamauchi T; Ueki K; Tobe K; Tamemoto H; Sekine N; Wada M; Honjo M; Takahashi M; Takahashi T; Hirai H; Tushima T; Akanuma Y; Fujita T; Komuro I; Yazaki Y; Kadowaki T
    Nature; 1997 Nov; 390(6655):91-6. PubMed ID: 9363897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation loop tyrosines allow the JAK2(V617F) mutant to attain hyperactivation.
    Kundrapu K; Colenberg L; Duhé RJ
    Cell Biochem Biophys; 2008; 52(2):103-12. PubMed ID: 18841497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
    Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
    J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the glucose carrier SGLT1 by JAK2.
    Hosseinzadeh Z; Bhavsar SK; Shojaiefard M; Saxena A; Merches K; Sopjani M; Alesutan I; Lang F
    Biochem Biophys Res Commun; 2011 May; 408(2):208-13. PubMed ID: 21406183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance.
    Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D
    J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tubulin as a substrate of Jak2 tyrosine kinase and its role in Jak2-dependent signaling.
    Ma X; Sayeski PP
    Biochemistry; 2007 Jun; 46(24):7153-62. PubMed ID: 17530781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis.
    Sobko A; Ma H; Firtel RA
    Dev Cell; 2002 Jun; 2(6):745-56. PubMed ID: 12062087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance.
    Li J; Wu R; Yung MMH; Sun J; Li Z; Yang H; Zhang Y; Liu SS; Cheung ANY; Ngan HYS; Braisted JC; Zheng W; Wei H; Gao Y; Nemes P; Pei H; Chan DW; Li Y; Zhu W
    Cell Death Dis; 2021 Apr; 12(4):341. PubMed ID: 33795649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylation of SAE2 C terminus regulates SAE nuclear localization.
    Truong K; Lee TD; Li B; Chen Y
    J Biol Chem; 2012 Dec; 287(51):42611-9. PubMed ID: 23095757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and nuclear translocation of sumoylated transmembrane fragment of cell adhesion molecule L1.
    Lutz D; Wolters-Eisfeld G; Joshi G; Djogo N; Jakovcevski I; Schachner M; Kleene R
    J Biol Chem; 2012 May; 287(21):17161-17175. PubMed ID: 22431726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relevance of JAK2 in the Regulation of Cellular Transport.
    Sopjani M; Konjufca V; Rinnerthaler M; Rexhepaj R; Dërmaku-Sopjani M
    Curr Med Chem; 2016; 23(6):578-88. PubMed ID: 26639094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.